Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
HF 22: CCM Therapy in Patients With HFpEF
Author(s): Cecilia Linde Added: 1 year ago
In this short interview, Dr Cecilia Linde (Karolinska University, SE) shares the findings of the CCM HFpEF Study. Originally presented at Heart Failure 22, this study aimed to evaluate the safety and efficacy of cardiac contractility modulation therapy in heart failure patients with preserved ejection fraction (HFpEF). Discussion Points: 1. Study Background 2. Study Design & Patient Population 3… View more

Heart Failure

Electrophysiology & Arrhythmia
Jaffar Khan
Job title: Staff Clinician
Jaffar is an interventional cardiologist and Staff Clinician at the NHLBI, NIH. He has a special interest in structural heart disease innovation. He co-invented transcatheter electrosurgical techniques to cut heart tissue, including LAMPOON to prevent LVOT obstruction from TMVR, BASILICA to prevent coronary obstruction from TAVR, and ELASTIC/ELASTA-Clip to displace a MitraClip to enable TMVR and… View more
Author(s): Marwan M Refaat , Jad Ballout , Moussa Mansour Added: 3 years ago
Although there is no formal database of adults with congenital heart disease (CHD) in the United States, the prevalence and incidence of CHD can be estimated and extrapolated from data in the Canadian providence.1 As such, the prevalence of CHD in the United States has been estimated in 2010 to be around 2.4 million people (1.4 million adults and 1 million children), with an incidence of between… View more

Electrophysiology & Arrhythmia

Heterogeneous Populations
Kevin Damman
Research Area(s) / Expertise:

Heart Failure

Imaging & Diagnostics

 Job title: Head of the Heart Transplant and Left Ventricular Device Program
Dr Kevin Damman is Head of the Heart Transplant and Left Ventricular Device Program at the University Medical Center Groningen in the Netherlands. His research interests focus on acute and advanced heart failure, including cardiorenal axis. He is also interested in improving the treatment of acute heart failure patients, with early assessment of decongestive therapies, SGLT2 inhibitors in… View more
Author(s): George D Katritsis , Demosthenes G Katritsis Added: 3 years ago
Implantable cardiac devices, such as pacemakers, are used to treat a number of heart conditions, especially those related to the electrical conduction system. Cardiac pacemakers are a well-established and effective therapy, and have been in use for more than 50 years. The first pacemaker was implanted in a patient in October 1958 by Åke Senning in Stockholm, in cooperation with engineer Rune… View more

Electrophysiology & Arrhythmia
Job title: Professor
Prof Paul Kalra is Professor of Cardiologyat Portsmouth Hospitals NHS Trust, UK.The majority of his work involves assessment, investigation and management of patients with known or suspected cardiac problems. While he has a broad interest in all aspects of general adult cardiology, his sub-specialty interest is the assessment and management of patients with heart failure. Prof Kalra has… View more
Author(s): Francisco Leyva , Mauro Biffi , Howard Marshall , et al Added: 3 years ago
Prof Francisco Leyva and Prof Mauro Biffi introduce this online video series, filmed in partnership with the BHRS. Through a series of 8 videos, they explain how faculty aim to draw parallels on hospital responses during the COVID-19 crisis and assess how treating patients in cardiology has been during this period and how cardiologists will continue to operate in what will be the new ‘normal’. View more

COVID-19

Electrophysiology & Arrhythmia
Author(s): Joshua R Silverstein , Demosthenes G Katritsis , Mark E Josephson Added: 3 years ago
Sudden cardiac death (SCD) is one of the leading causes of death in developed countries. The yearly incidence of SCD is estimated to be 3,000,000 worldwide and between 300,000–450,000 in both the US and Western Europe.1,2 The survival rate for SCD is <1 % worldwide and close to 5 % in the developed world.3 In the past, cardiac arrest was thought to be most commonly due to ventricular… View more

Electrophysiology & Arrhythmia
Ventricular Assist Device - ABIOMED, Inc.
Abiomed: Manufacturer of Impella®Percutaneous Ventricular Assist Device Abiomed, founded in 1981, is a global pioneer in healthcare technology, with a mission to recover hearts and save lives. From the World’s first total replacement heart pump to the World’s smallest heart pump, Abiomed has developed a family of ventricular assist devices (VAD), namely the Impella® platform of percutaneous… View more
Author(s): Thorsten Lewalter , Giuseppe Boriani Added: 3 years ago
The monitoring of atrial fibrillation (AF) can be performed using a great variety of strategies and tools. Strategies range from monitoring only symptomatic AF (e.g., post-catheter ablation with or without surface electrocardiogram [ECG] documentation) to continuously monitoring heart rhythm using implantable pacemakers, implantable cardioverter defibrillators (ICDs) or subcutaneous implantable… View more

Imaging & Diagnostics

Electrophysiology & Arrhythmia